BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37944215)

  • 21. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
    Taylor MA; Parvani JG; Schiemann WP
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
    Yuki R
    Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
    Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
    Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition.
    Sommerova L; Ondrouskova E; Vojtesek B; Hrstka R
    BMC Cancer; 2017 Aug; 17(1):546. PubMed ID: 28810836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancer Reprogramming within Pre-existing Topologically Associated Domains Promotes TGF-β-Induced EMT and Cancer Metastasis.
    Qiao Y; Wang Z; Tan F; Chen J; Lin J; Yang J; Li H; Wang X; Sali A; Zhang L; Zhong G
    Mol Ther; 2020 Sep; 28(9):2083-2095. PubMed ID: 32526202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion.
    Lamouille S; Connolly E; Smyth JW; Akhurst RJ; Derynck R
    J Cell Sci; 2012 Mar; 125(Pt 5):1259-73. PubMed ID: 22399812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visualizing Dynamic Changes During TGF-β-Induced Epithelial to Mesenchymal Transition.
    Sinha A; Mehta P; Fan C; Zhang J; Marvin DL; van Dinther M; Ritsma L; Boukany PE; Ten Dijke P
    Methods Mol Biol; 2022; 2488():47-65. PubMed ID: 35347682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
    Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
    Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
    Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
    Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β induced EMT and stemness characteristics are associated with epigenetic regulation in lung cancer.
    Kim BN; Ahn DH; Kang N; Yeo CD; Kim YK; Lee KY; Kim TJ; Lee SH; Park MS; Yim HW; Park JY; Park CK; Kim SJ
    Sci Rep; 2020 Jun; 10(1):10597. PubMed ID: 32606331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.
    Ping Q; Wang C; Cheng X; Zhong Y; Yan R; Yang M; Shi Y; Li X; Li X; Huang W; Wang L; Bi X; Hu L; Yang Y; Wang Y; Gong R; Tan J; Li R; Li H; Li J; Wang W; Li R
    J Transl Med; 2023 Jul; 21(1):475. PubMed ID: 37461061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FAD104, a regulator of adipogenesis, is a novel suppressor of TGF-β-mediated EMT in cervical cancer cells.
    Goto M; Osada S; Imagawa M; Nishizuka M
    Sci Rep; 2017 Nov; 7(1):16365. PubMed ID: 29180690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
    Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
    Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wilms tumor 1 associated protein promotes epithelial mesenchymal transition of gastric cancer cells by accelerating TGF-β and enhances chemoradiotherapy resistance.
    Liu Y; Da M
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3977-3988. PubMed ID: 36030434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.
    Ruff M; Leyme A; Le Cann F; Bonnier D; Le Seyec J; Chesnel F; Fattet L; Rimokh R; Baffet G; Théret N
    PLoS One; 2015; 10(9):e0139179. PubMed ID: 26407179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
    Huang T; Huang W; Lu H; Zhang BY; Ma J; Zhao D; Wang YJ; Yu DH; He X
    J Transl Med; 2018 Feb; 16(1):46. PubMed ID: 29490660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas.
    Ho KH; Chen PH; Shih CM; Lee YT; Cheng CH; Liu AJ; Lee CC; Chen KC
    Cell Mol Neurobiol; 2022 Apr; 42(3):791-806. PubMed ID: 33025417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer upregulated gene 2 induces epithelial-mesenchymal transition of human lung cancer cells via TGF-β signaling.
    Kaowinn S; Kim J; Lee J; Shin DH; Kang CD; Kim DK; Lee S; Kang MK; Koh SS; Kim SJ; Chung YH
    Oncotarget; 2017 Jan; 8(3):5092-5110. PubMed ID: 27974707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.